GLP-1 receptor agonists alleviate inflammatory responses and endothelial dysfunction in atherosclerosis by activating the Sema3A/NRP1 pathway

Lin Hu, Sanjun Li, Xiaoqin Deng, Zhipeng Zhou, Liu Yang, Bin Li

Open source

DOI: 10.3389/fcvm.2026.1836833
Published: 2026-05-12
Container: Frontiers in Cardiovascular Medicine
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1836833,
  title = {GLP-1 receptor agonists alleviate inflammatory responses and endothelial dysfunction in atherosclerosis by activating the Sema3A/NRP1 pathway},
  author = {Lin Hu and Sanjun Li and Xiaoqin Deng and Zhipeng Zhou and Liu Yang and Bin Li},
  year = {2026},
  journal = {Frontiers in Cardiovascular Medicine},
  doi = {10.3389/fcvm.2026.1836833},
  url = {https://doi.org/10.3389/fcvm.2026.1836833}
}

RIS

TY  - JOUR
TI  - GLP-1 receptor agonists alleviate inflammatory responses and endothelial dysfunction in atherosclerosis by activating the Sema3A/NRP1 pathway
AU  - Lin Hu
AU  - Sanjun Li
AU  - Xiaoqin Deng
AU  - Zhipeng Zhou
AU  - Liu Yang
AU  - Bin Li
PY  - 2026
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2026.1836833
UR  - https://doi.org/10.3389/fcvm.2026.1836833
ER  -

APA

Hu, L., Li, S., Deng, X., Zhou, Z., Yang, L., & Li, B. (2026). GLP-1 receptor agonists alleviate inflammatory responses and endothelial dysfunction in atherosclerosis by activating the Sema3A/NRP1 pathway. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2026.1836833

Source records

crossref · retrieved 2026-09-26T22:03:25.929Z